Researchers have turned to the world of plants to combat the aggressiveness and resistance to therapy of Epstein-Barr virus (EBV)–positive head and neck cancer (HNC) cells. Specifically, they have examined the potential therapeutic effects of Euphorbis tirucalli, or the pencil cactus, leaf extract because of the plant’s ability to inhibit EBV-positive cell proliferation. Results were published in Medicinal Chemistry. ...
Oncology
Advertisement
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Researchers assessed ICD gene expressions to predict immunotherapy response and immune cell infiltration.
Dr. John Fruehauf details how novel therapies have improved the landscape of metastatic melanoma care.
Dr. Amin Mirhadi details the benefits and disadvantages of using proton therapy in patients with head and neck cancer.
The global burden of cervical cancer, as well as cervical cancer mortality, is predicted to increase substantially by 2030.
Researchers identified 23,450 trial sites; a majority of them began before 2020.
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
Subgroup analyses of multiple diagnostic performance metrics in high vs low-income communities were also performed.
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
A study compared the screening performances of a tools used in cervical cancer screening in HIV-positive women.
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.